We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-13.93%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$20B
AUM Growth
-$5.25B
Cap. Flow
-$1.13B
Cap. Flow %
-5.62%
Top 10 Hldgs %
21.83%
Holding
1,650
New
389
Increased
426
Reduced
533
Closed
104

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$109M
2
ABBV icon
AbbVie
ABBV
+$68.7M
3
ORCL icon
Oracle
ORCL
+$63.5M
4
KO icon
Coca-Cola
KO
+$54.4M
5
ABT icon
Abbott
ABT
+$52.2M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$112M
2
AAPL icon
Apple
AAPL
+$97.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$87.3M
4
NVDA icon
NVIDIA
NVDA
+$66.6M
5
MSFT icon
Microsoft
MSFT
+$63M

Sector Composition

Rank Sector Weight
1 Technology 26.14%
2 Healthcare 21.45%
3 Financials 13.18%
4 Consumer Discretionary 9.11%
5 Consumer Staples 7.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
51
Micron Technology
MU
$835B
$86.6M 0.43%
1,566,899
-34,665
-2% -$2.35M
A icon
52
Agilent Technologies
A
$39.6B
$84.9M 0.42%
714,745
-14,581
-2% -$1.79M
VMW
53
DELISTED
VMware, Inc
VMW
$84.2M 0.42%
738,752
-185,348
-20% -$21M
SNPS icon
54
Synopsys
SNPS
$71.6B
$84.1M 0.42%
276,876
-68,015
-20% -$20.5M
HD icon
55
Home Depot
HD
$337B
$83.7M 0.42%
305,053
-96,682
-24% -$28.5M
PANW icon
56
Palo Alto Networks
PANW
$256B
$82.7M 0.41%
1,004,538
-624,984
-38% -$55.4M
CVS icon
57
CVS Health
CVS
$135B
$82.2M 0.41%
887,050
+176
+0% +$17.2K
QCOM icon
58
Qualcomm
QCOM
$164B
$82.1M 0.41%
642,416
-157,473
-20% -$21.4M
BRK.B icon
59
Berkshire Hathaway Class B
BRK.B
$1.1T
$82M 0.41%
300,261
-9,790
-3% -$3.07M
VRTX icon
60
Vertex Pharmaceuticals
VRTX
$123B
$81.7M 0.41%
289,976
+11,537
+4% +$3.09M
YUM icon
61
Yum! Brands
YUM
$41.9B
$79.9M 0.4%
703,483
-159,541
-18% -$18.5M
PRU icon
62
Prudential Financial
PRU
$42.6B
$76.7M 0.38%
801,275
-32,641
-4% -$3.45M
MRSH
63
Marsh
MRSH
$94.3B
$76.5M 0.38%
492,933
+12,246
+3% +$1.96M
DOV icon
64
Dover
DOV
$26.7B
$75.7M 0.38%
624,335
-20,038
-3% -$2.71M
CMCSA icon
65
Comcast
CMCSA
$87.3B
$75.5M 0.38%
1,923,688
-289,452
-13% -$12.4M
HPQ icon
66
HP
HPQ
$26B
$75M 0.37%
2,288,269
-839,601
-27% -$30.8M
EBAY icon
67
eBay
EBAY
$51.2B
$74.4M 0.37%
1,786,476
-426,560
-19% -$20.8M
SYK icon
68
Stryker
SYK
$135B
$74.4M 0.37%
373,925
-18,038
-5% -$4.24M
CVX icon
69
Chevron
CVX
$382B
$73.6M 0.37%
508,443
-5,455
-1% -$902K
VZ icon
70
Verizon
VZ
$197B
$72.5M 0.36%
1,427,614
+1,768
+0.1% +$89.4K
XOM icon
71
ExxonMobil
XOM
$650B
$71.6M 0.36%
836,392
-121,424
-13% -$11M
AMGN icon
72
Amgen
AMGN
$209B
$68.4M 0.34%
281,265
+134,140
+91% +$32.9M
DELL icon
73
Dell
DELL
$239B
$68M 0.34%
1,472,407
-454,720
-24% -$21.5M
MELI icon
74
Mercado Libre
MELI
$94.5B
$67.4M 0.34%
105,834
-1,990
-2% -$1.73M
CTXS
75
DELISTED
Citrix Systems Inc
CTXS
$65.4M 0.33%
673,163
-146,061
-18% -$14.5M

Similar funds

KBC Group's Q2 2022 Portfolio in Review

As of Q2 2022, KBC Group held 1,650 positions worth $20B, down 21% from $25.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

KBC Group withdrew a net $1.13B in Q2 2022, closing 104 positions and reducing 533 holdings. Its most notable exit was Cerner Corp, an estimated $17.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in AstraZeneca worth $1.34M.

  • KBC Group's largest Q2 2022 buy was AstraZeneca: 10,181 shares worth $1.34M.
  • KBC Group added most to Merck in Q2 2022, an estimated $109M increase.
  • KBC Group's biggest Q2 2022 reduction was Amazon, cutting an estimated $112M.
  • KBC Group fully exited Cerner Corp in Q2 2022, selling an estimated $17.5M.
  • KBC Group's ten largest holdings make up 22% of its $20B portfolio in Q2 2022.
  • KBC Group opened 389 new positions and closed 104 in Q2 2022.
  • KBC Group's portfolio value fell 21% quarter-over-quarter to $20B.

Based on KBC Group's 13F filing for Q2 2022, filed 26 Jul 2022.